DAP.XETRA Danaher Corporation

Healthcare Biotechnology XETRA Stock Exchange
200.80 EUR
Close of Nov 6, 2026
137.66 214.50
Market cap
EUR 141B
P/E
38.6x
P/B
3.04x
ROE
8.0%
Dividend yield
0.69%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is DAP.XETRA undervalued?

Graham number
Price200.80
Graham value87.93
Premium128.4%

DAP.XETRA trades 128.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Danaher Corporation fundamental analysis

No fundamental analysis for Danaher Corporation yet.

Danaher Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development…

Full company profile